Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00539422What this trial is testingRole of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast DiseasesWho this might be right forBreast Cancer Mansoura University
Testing effectiveness (Phase 2)Study completedNCT05653856What this trial is testingCu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate CancerWho this might be right forMetastasis From Malignant Tumor of Prostate (Disorder) Curium US LLC 26
Not applicableLooking for participantsNCT07193329What this trial is testingPsychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of LifeWho this might be right forPsychological DistressMalignant Tumor Gang Chen, MD 2,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344What this trial is testingTesting Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 53
Not applicableActive Not RecruitingNCT06295367What this trial is testingCost Communication and Financial Navigation in Cancer Patients (COSTCOM)Who this might be right forMalignant Solid Neoplasm ECOG-ACRIN Cancer Research Group 760
Testing effectiveness (Phase 2)Study completedNCT01371201What this trial is testingFirst International Randomized Study in Malignant Progressive Pheochromocytoma and ParagangliomaWho this might be right forMalignant Progressive Pheochromocytoma and Paraganglioma (PPGL) Gustave Roussy, Cancer Campus, Grand Paris 78
Testing effectiveness (Phase 2)Study completedNCT02285439What this trial is testingStudy of MEK162 for Children With Low-Grade GliomasWho this might be right forLow-Grade GliomasMalignant Neoplasms, BrainSoft Tissue Neoplasms Children's Hospital Los Angeles 105
Testing effectiveness (Phase 2)Study completedNCT00870181What this trial is testingADV-TK Improves Outcome of Recurrent High-Grade GliomaWho this might be right forMalignant Glioma of BrainGlioblastoma Huazhong University of Science and Technology 47
Testing effectiveness (Phase 2)Study completedNCT04238819What this trial is testingAbemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaWho this might be right forRelapsed Solid TumorRefractory Solid Tumor Eli Lilly and Company 47
Not applicableUnknownNCT03047811What this trial is testingThe Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid TumorsWho this might be right forAdvanced Malignant Solid Tumors Fudan University 15
Testing effectiveness (Phase 2)Looking for participantsNCT06470971What this trial is testingSiltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES TrialWho this might be right forAdvanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm Yuanquan Yang 40
Testing effectiveness (Phase 2)Study completedNCT00509041What this trial is testingDasatinib in Treating Patients With Previously Treated Malignant MesotheliomaWho this might be right forMalignant Mesothelioma Alliance for Clinical Trials in Oncology 46
Not applicableActive Not RecruitingNCT03244995What this trial is testingMind-Body Intervention in Glioma CouplesWho this might be right forGlioblastomaLow Grade GliomaMalignant Glioma+3 more M.D. Anderson Cancer Center 74
Testing effectiveness (Phase 2)Study completedNCT00002657What this trial is testingSWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm SWOG Cancer Research Network 20
Early research (Phase 1)Looking for participantsNCT06878612What this trial is testingA Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid TumorsWho this might be right forPolyphenolsCancer VaccineAdvanced Solid Tumor Xingchen Peng 9
Large-scale testing (Phase 3)UnknownNCT01914107What this trial is testingReal-time Cancer Pain Assessment and InterventionWho this might be right forMalignancyPain Sun Yat-sen University 200
Testing effectiveness (Phase 2)Ended earlyNCT02663271What this trial is testingTTFields and Pulsed Bevacizumab for Recurrent GlioblastomaWho this might be right forGlioblastoma MultiformeGlioblastomaMalignant Glioma+1 more University of Florida 10
Large-scale testing (Phase 3)Looking for participantsNCT07044336What this trial is testingPuxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)Who this might be right forEndometrial CancerMalignant Solid Tumour AstraZeneca 800
Early research (Phase 1)Study completedNCT03009201What this trial is testingRibociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by SurgeryWho this might be right forAdvanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced Leiomyosarcoma+24 more OHSU Knight Cancer Institute 16